부산대학교 도서관

Kumari, R; Hummerich, H; Shen, X; Fischer, M; Litovchick, L; Mittnacht, S; DeCaprio, JA; Jat, PS

Sci Rep
Scientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)

Nusbaum, C; Zody, MC; Borowsky, ML; Kamal, M; Kodira, CD; Taylor, TD; Whittaker, CA; Chang, JL; Cuomo, CA; Dewar, K; FitzGerald, MG; Yang, XP; Abouelleil, A; Allen, NR; Anderson, S; Bloom, T; Bugalter, B; Butler, J; Cook, A; DeCaprio, D; Engels, R; Garber, M; Gnirke, A; Hafez, N; Hall, JL; Norman, CH; Itoh, T; Jaffe, DB; Kuroki, Y; Lehoczky, J; Lui, A; Macdonald, P; Mauceli, E; Mikkelsen, TS; Naylor, JW; Nicol, R; Nguyen, C; Noguchi, H; O'Leary, SB; Piqani, B; Smith, CL; Talamas, JA; Topham, K; Totoki, Y; Toyoda, A; Wain, HM; Young, SK; Zeng, QD; Zimmer, AR; Fujiyama, A; Hattori, M; Birren, BW; Sakaki, Y; Lander, ES; Takehiko Itoh

Nature. 437:551-555

Urashima, M; Teoh, G; Ogata, A; Chauhan, D; Treon, SP; Hoshi, Y; DeCaprio, JA; Anderson, KC

Leukemia. 11(11):1957-1963

Lobo MM; Cutaneous Oncology Department, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Duprat Neto JP; Cutaneous Oncology Department, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil.; Silva MJBE; Medical Oncology Department, A. C. Camargo Cancer Center, São Paulo, São Paulo, Brazil.; Munhoz RR; Oncology Center, Hospital Sírio Libanês, São Paulo, São Paulo, Brazil.; de Melo AC; Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Rio de Janeiro, Brazil.; Pinheiro RN; Surgical Oncology Service, Base Hospital of Federal District, Federal District, Brasília, Brazil.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: In Process; MEDLINE

Bahar F; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE

Schnabel JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.; Frost TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.; Wang AC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ananthapadmanabhan V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Gurram S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Northeastern University, Dana-Farber/Harvard Cancer Center, CaNCURE, Cancer Nanomedicine Co-ops for Undergraduate Research Experience, Boston, MA, USA.; Soroko KM; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, MA, USA.; Gokhale PC; Experimental Therapeutics Core, Dana-Farber Cancer Institute, Boston, MA, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Yang J; University of Arizona Cancer Center, Tucson, Arizona, USA.; Lim JT; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.; Santiago Raj PV; Department of Pharmacology and Toxicology, The University of Arizona R. Ken Coit College of Pharmacy, Skaggs Pharmaceutical Sciences Center, Tucson, Arizona, USA.; Corona MG; University of Arizona Cancer Center, Tucson, Arizona, USA.; Chen C; University of Arizona Cancer Center, Tucson, Arizona, USA.; Department of Epidemiology and Biostatistics, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.; Khawaja H; University of Arizona Cancer Center, Tucson, Arizona, USA.; Pan Q; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.; Paine-Murrieta GD; University of Arizona Cancer Center, Tucson, Arizona, USA.; Schnellmann RG; Department of Pharmacology and Toxicology, The University of Arizona R. Ken Coit College of Pharmacy, Skaggs Pharmaceutical Sciences Center, Tucson, Arizona, USA.; The University of Arizona College of Medicine, Tucson, Arizona, USA.; The University of Arizona, BIO5 Institute, Tucson, Arizona, USA.; Southern Arizona VA Health Care System, Tucson, Arizona, USA.; Roe DJ; Department of Epidemiology and Biostatistics, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.; Gokhale PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Padi M; University of Arizona Cancer Center, Tucson, Arizona, USA.; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

Yang J; University of Arizona Cancer Center, Tucson, Arizona, USA.; Lim JT; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.; Victor P; Department of Pharmacology and Toxicology, The University of Arizona R. Ken Coit College of Pharmacy, Skaggs Pharmaceutical Sciences Center, Tucson, Arizona, USA.; Corona MG; University of Arizona Cancer Center, Tucson, Arizona, USA.; Chen C; University of Arizona Cancer Center, Tucson, Arizona, USA.; Department of Epidemiology and Biostatistics, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.; Khawaja H; University of Arizona Cancer Center, Tucson, Arizona, USA.; Pan Q; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.; Paine-Murrieta GD; University of Arizona Cancer Center, Tucson, Arizona, USA.; Schnellmann RG; Department of Pharmacology and Toxicology, The University of Arizona R. Ken Coit College of Pharmacy, Skaggs Pharmaceutical Sciences Center, Tucson, Arizona, USA.; The University of Arizona College of Medicine, Tucson, Arizona, USA.; The University of Arizona, BIO5 Institute, Tucson, Arizona, USA.; Southern Arizona VA Health Care System, USA.; Roe DJ; Department of Epidemiology and Biostatistics, University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.; Gokhale PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Padi M; University of Arizona Cancer Center, Tucson, Arizona, USA.; Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Booth CAG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Bouyssou JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Togami K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Armand O; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Rivas HG; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA.; Yan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Rice S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Cheng S; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York, USA.; Departments of Pediatrics, Pharmacology, and Physiology & Biophysics, Weill Medical College of Cornell University, New York, New York, USA.; Lachtara EM; Krantz Family Center for Cancer Research, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Bourquin JP; Division of Oncology, Children's Research Center, University Children's Hospital, Zurich, Switzerland.; Kentsis A; Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Molecular Pharmacology Program, Sloan Kettering Institute, New York, New York, USA.; Departments of Pediatrics, Pharmacology, and Physiology & Biophysics, Weill Medical College of Cornell University, New York, New York, USA.; Rheinbay E; Krantz Family Center for Cancer Research, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Lane AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

Nomburg J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.; Bullman S; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Nasrollahzadeh D; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France.; Collisson EA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA.; Abedi-Ardekani B; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France.; Akoko LO; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Atkins JR; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France.; Buckle GC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA.; Gopal S; University of North Carolina (UNC), Chapel Hill, North Carolina, USA.; Hu N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Kaimila B; UNC Project, Lilongwe, Malawi.; Khoshnia M; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.; Malekzadeh R; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.; Menya D; School of Public Health, Moi University, Eldoret, Kenya.; Mmbaga BT; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center, Moshi, Tanzania.; Kilimanjaro Christian Medical University College, Moshi, Tanzania.; Moody S; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Trust Sanger Institute, Cambridgeshire, UK.; Mulima G; Kamuzu Central Hospital, Lilongwe, Malawi.; Mushi BP; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Mwaiselage J; Ocean Road Cancer Institute, Dar es Salaam, Tanzania.; Mwanga A; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Newton Y; NantOmics/NantHealth, Inc., El Segundo, California, USA.; Ng DL; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Pathology, UCSF, San Francisco, California, USA.; Radenbaugh A; NantOmics/NantHealth, Inc., El Segundo, California, USA.; Rwakatema DS; Kilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Center, Moshi, Tanzania.; Kilimanjaro Christian Medical University College, Moshi, Tanzania.; Selekwa M; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Schüz J; International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.; Taylor PR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Vaske C; NantOmics/NantHealth, Inc., El Segundo, California, USA.; Goldstein A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Stratton MR; The Cancer, Ageing and Somatic Mutation Programme, Wellcome Trust Sanger Institute, Cambridgeshire, UK.; McCormack V; International Agency for Research on Cancer (IARC/WHO), Environment and Lifestyle Epidemiology Branch, Lyon, France.; Brennan P; International Agency for Research on Cancer (IARC), Genomic Epidemiology Branch, Lyon, France.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Program in Virology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA.; Mmbaga EJ; Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Department of Community Medicine and Global Health, University of Oslo, Oslo, Norway.; Van Loon K; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, California, USA.; Division of Hematology/Oncology, Department of Medicine, UCSF, San Francisco, California, USA.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Spurgeon ME; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.; Cheng J; Department of Molecular, Cellular and Biomedical Sciences, University of New Hampshire, Durham, New Hampshire, United States of America.; Ward-Shaw E; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.; Dick FA; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Children's Health Research Institute, London, Ontario, Canada.; London Regional Cancer Program, London Health Sciences Centre, London, Ontario, Canada.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Lambert PF; McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Nomburg J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.; Harvard Program in Virology, Harvard University Graduate School of Arts and Sciences, Boston, Massachusetts, United States of America.; Zou W; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.; Frost TC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Harvard Program in Virology, Harvard University Graduate School of Arts and Sciences, Boston, Massachusetts, United States of America.; Datta C; Massachusetts General Hospital Cancer Center, Harvard Medical School, 185 Cambridge St, CPZN4202, Boston, Massachusetts, United States of America.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, United States of America.; Vasudevan S; Massachusetts General Hospital Cancer Center, Harvard Medical School, 185 Cambridge St, CPZN4202, Boston, Massachusetts, United States of America.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.; Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts, United States of America.; Starrett GJ; Laboratory of Cellular Oncology, CCR, NCI, NIH, Bethesda, Maryland, United States of America.; Imperiale MJ; Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, United States of America.; Rogel Cancer Center, Ann Arbor, Michigan, United States of America.; Meyerson M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America.; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.; Harvard Program in Virology, Harvard University Graduate School of Arts and Sciences, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Fischer M; Computational Biology Group, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11, 07745 Jena, Germany.; Schwarz R; Computational Biology Group, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11, 07745 Jena, Germany.; Riege K; Computational Biology Group, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11, 07745 Jena, Germany.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Hoffmann S; Computational Biology Group, Leibniz Institute on Aging - Fritz Lipmann Institute (FLI), Beutenbergstraße 11, 07745 Jena, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: PubMed not MEDLINE

Choudhury R; Bonacci T; Arceci A; Lahiri D; Mills CA; Kernan JL; Branigan TB; DeCaprio JA; Burke DJ; Emanuele MJ

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: PubMed not MEDLINE; MEDLINE

Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Davidsohn MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Fortunato B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Sotudian S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Lakshminarayanan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Diossy M; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Madueke I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Li R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Jiang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Taing L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Awad M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Greten TF; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Hata AN; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hughes ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ligon KL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lin N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Meador C; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Parsons HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Rajan A; Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Thakuria M; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Long H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Szallasi Z; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Danish Cancer Institute, Copenhagen, Denmark.; Department of Bioinformatics and Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. matthew_freedman@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. matthew_freedman@dfci.harvard.edu.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA. matthew_freedman@dfci.harvard.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: PubMed not MEDLINE; MEDLINE

Martins C; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Rasbach E; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Surgery, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; Heppt MV; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University (FAU), 91054 Erlangen, Germany.; Singh P; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Kulcsar Z; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, University Hospital Bonn, 53127 Bonn, Germany.; Holzgruber J; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology and Venerology, Johannes Kepler University, 4020 Linz, Austria.; Chakraborty A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Mucciarone K; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Kleffel S; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Brandenburg A; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, University Hospital Bonn, 53127 Bonn, Germany.; Hoetzenecker W; Department of Dermatology and Venerology, Johannes Kepler University, 4020 Linz, Austria.; Rahbari NN; Department of Surgery, University Hospital Mannheim, Heidelberg University, 68167 Mannheim, Germany.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.; Program in Virology, Graduate School of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham and Women's Hospital Cancer Center, Boston, MA 02115, USA.; Thakuria M; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Merkel Cell Carcinoma Center of Excellence, Dana-Farber/Brigham and Women's Hospital Cancer Center, Boston, MA 02115, USA.; Murphy GF; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Ramsey MR; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Posch C; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Dermatology, Vienna Healthcare Group, 1130 Vienna, Austria.; Faculty of Medicine, Sigmund Freud University Vienna, 1020 Vienna, Austria.; Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, 81675 Munich, Germany.; Barthel SR; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Schatton T; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Program of Glyco-Immunology and Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.; Department of Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Davidsohn MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Fortunato B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Semaan K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Sotudian S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Lakshminarayanan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Diossy M; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Qiu X; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Savignano H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Canniff J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Madueke I; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Saliby RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Li R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Jiang Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Taing L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Awad M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; DeCaprio JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Greten TF; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Hata AN; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hughes ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ligon KL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lin N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Oser MG; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Meador C; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Parsons HA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Rajan A; Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, MD, USA.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Thakuria M; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Center for Cutaneous Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, MA, USA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Long H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.; Szallasi Z; Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.; Danish Cancer Institute, Copenhagen, Denmark.; Department of Bioinformatics and Department of Pathology, Forensic and Insurance Medicine, Semmelweis University, Budapest, Hungary.; Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. matthew_freedman@dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA. matthew_freedman@dfci.harvard.edu.; Eli and Edythe L. Broad Institute, Cambridge, MA, USA. matthew_freedman@dfci.harvard.edu.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Poulin, DL; DeCaprio, JA

VIROLOGY; MAY 25 2006, 349 1, p212-p221, 10p.

Borger, DR; DeCaprio, JA

JOURNAL OF VIROLOGY; MAY 2006, 80 9, p4292-p4303, 12p.

Rodig SJ; Cheng J; Wardzala J; Dorosario A; Scanlon JJ; Laga AC; Martinez-Fernandez A; Barletta JA; Bellizzi AM; Sadasivam S; Holloway DT; Cooper DJ; Kupper TS; Wang LC; Decaprio JA; Rodig, Scott J; Cheng, Jingwei; Wardzala, Jacek; DoRosario, Andrew; Scanlon, Jessica J; et al

Journal of Clinical Investigation (J CLIN INVEST), Dec2012; 122(12): 4645-4653. (9p)